CN106983849A - A kind of Chinese medicine for treating apoplexy and application - Google Patents
A kind of Chinese medicine for treating apoplexy and application Download PDFInfo
- Publication number
- CN106983849A CN106983849A CN201710360148.XA CN201710360148A CN106983849A CN 106983849 A CN106983849 A CN 106983849A CN 201710360148 A CN201710360148 A CN 201710360148A CN 106983849 A CN106983849 A CN 106983849A
- Authority
- CN
- China
- Prior art keywords
- medicine
- apoplexy
- radix
- angelicae sinensis
- almond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine for treating apoplexy and its application, described medicine with following raw materials by being made：Rhizoma zingiberis, Ligusticum wallichii, Radix Angelicae Sinensis, radix glycyrrhizae, radix scutellariae, osmanthus heart, almond, gypsum, jute.The present invention specify that the formula and preparation method of medicine, overcome the deficiency of existing treatment apoplexy medicine, and function admirable, the therapeutic effect of Patients with Apoplexy After is good.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines, and in particular to a kind of Chinese medicine for treating apoplexy and application.
Background technology
Apoplexy usually brings three inclined symptoms：Hemiplegia, hemidysesthesia, hemianopsia, and lost with dysphonia or motility
Language.In a big way or multiple relapse sequelae symptom can leave spirit and dysnoesia.Therefore to the prevention of apoplexy with controlling
The research for the treatment of causes the very big concern of people always.
Chinese invention patent 105658667A, which is related to, treats apoplexy such as ishemic stroke such as acute ischemic stroke
Method, and it is for example acute scarce with apoplexy such as ishemic stroke to be directed to use with such as natalizumab reduction of VLA-4 antagonists
The method of the related infraction size of courageous and upright apoplexy and/or other neurologically handicappeds.It was found that, such as when specified after apoplectic seizure
Between when being administered in section, VLA-4 antagonists such as natalizumab can effectively reduce apoplexy such as ishemic stroke for example
The infraction size of the acute ischemic stroke neurologically handicapped related to other.
Chinese invention patent 101843851B is related to the preparation of anti-hypertension apoplexy medicine, it is desirable to provide a kind of anti-hypertension
Dendrobium officinale nimodipine combination medicine of apoplexy and preparation method thereof.The dendrobium candidum Nimodipine of the anti-hypertension apoplexy is closed
With medicine, effective component includes the mass ratio of dendrobium officinale aqueous extract and Nimodipine, dendrobium officinale aqueous extract and Nimodipine
For 1.0~4.0: 0.12~0.24.The invention is additionally provided in the medicinal extract based on the medicine, granule, tablet, capsule, medicine
Mesosome and preparation method thereof.The invention, which discloses the use of combination with medication and dendrobium candidum or the independent of Nimodipine any one, to be made
With comparing, not only can be faster reduce blood pressure is better able to the reduction death rate, extension life span.Such as spy
The medicine for determining purposes is used, and can relax lasting reduction hyperpietic's blood pressure, delays hypertensive cerebral vascular infringement progress,
To mankind's preventing hypertension apoplexy, the disabling of reduction high blood pressure, fatal rate are significant.
Chinese invention patent 102614234B discloses a kind of Aggrenox compositions and tablet and preparation method thereof.Side
Method：Crude drug Ligusticum wallichii and Radix Angelicae Sinensis are added into 10 times of 70% ethanol of amount for the first time, extractor is placed in, keeps 70-100 DEG C of extraction 2 small
When, extract solution is filtered out, the first extract solution is obtained, solid filter residue is stand-by.8 times of 70% ethanol of amount are added in solid filter residue, are placed in
Extractor, is kept for 70-100 DEG C extract 1.5 hours, filters out extract solution, filter out extract solution, obtains the second extract solution and solid filter
Slag.Mixed extract, under the conditions of temperature is 60-70 DEG C, no alcohol taste is concentrated under reduced pressure into mixed liquor, obtains extracting concentration
Thing, the relative density of concentrate is 1.10~1.30, and its Midst density is measured at 60 DEG C；Add what is crushed in extraction concentrat
Natural borneol dissolves, and produces Pharmaceutical composition；The weight proportion of medicinal material used is：10~50 parts of Ligusticum wallichii, Radix Angelicae Sinensis 50~10 part, day
Right 1~10 part of borneol.Obtained composition has obvious repair to apoplexy, the impaired of cranial nerve function.
However, the effect of the medicine of Current therapeutic apoplexy is not good, apoplexy is still to seriously endanger human health and life
The common refractory disease of safety.According to statistics, the annual patient for occurring headstroke of China is just up to 2,000,000.Now survive apoplexy
Patient 7,000,000, wherein the different degrees of disability of 4,500,000 patients and can't take care of oneself, disability rate is up to 75%.It is Chinese every
Year stroke patient dead 1,200,000.
The content of the invention
Goal of the invention：In order to improve the therapeutic effect of stroke patient, the invention provides a kind of Chinese medicine for treating apoplexy.
To achieve the above object, by a large amount of practices of inventor, medicine of the invention is made up of following raw materials：
Rhizoma zingiberis, Ligusticum wallichii, Radix Angelicae Sinensis, radix glycyrrhizae, radix scutellariae, osmanthus heart, almond, gypsum, jute.
Preferably, to being limited below the work by weight ratio of each component：
1 part of rhizoma zingiberis；Ligusticum wallichii, each 0.8 ~ 1.5 part of Radix Angelicae Sinensis, radix glycyrrhizae, radix scutellariae；Each 8 ~ 12 parts of osmanthus heart, almond；Gypsum, jute each 15 ~ 25
Part.
Further preferably, medicine of the invention is made up by weight of following raw materials according：
Rhizoma zingiberis, Ligusticum wallichii, each 1 part of Radix Angelicae Sinensis, radix glycyrrhizae, radix scutellariae；Each 10 parts of osmanthus heart, almond；Each 20 parts of gypsum, jute.
The formulation of pharmaceutical composition of the present invention can be the medical science such as decoction, pill, powder, tablet, capsule, granule
Upper acceptable formulation, preparation is processed by existing common process.
Present invention additionally comprises said medicine for treating the application in apoplexy.
The pharmaceutical formulation of the present invention, for the pathogenesis of apoplexy, has warming spleen and stomach for dispelling cold, Back to Yang Tongmai, temperature from rhizoma zingiberis
The effect of lungization drink；Ligusticum wallichii has promoting qi circulation and relieving pain, warming kidney and enhancing yang, the broken product effect of stagnation resolvation；Radix Angelicae Sinensis has the effect of replenishing and activating blood；It is sweet
Grass, which has, invigorates the spleen and benefits qi, clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription.For weakness of the spleen and the stomach, lassitude hypodynamia, the heart
Throb with fear shortness of breath, coughing with a lot of sputum, gastral cavity abdomen, four limbs contraction, carbuncle sore tumefacting virus alleviate drug toxicity, strong effect；Almond has drop
The effect of blood fat；Radix scutellariae has the effect of heat-clearing and damp-drying drug, purging intense heat and detonicating, hemostasis, hypotensive；Zhu Fang is shared, and can reach sample
The simultaneous purpose controlled, has good curative effect to symptoms such as apoplexy, cerebral infarction, miocardial infarction, acute cerebral hemorrhage diseases.
Embodiment
The present invention is further illustrated with reference to embodiment.
Take rhizoma zingiberis, Ligusticum wallichii, each 10 grams of Radix Angelicae Sinensis, radix glycyrrhizae, radix scutellariae；Each 100 grams of osmanthus heart, almond；Each 200 grams of gypsum, jute, it is standby
With；Jute is put into 10 liters of water, boiled, is filtered, is added other all medicinal materials, boil, obtain decoction.
Claims (5)
1. a kind of medicine, it is characterised in that the medicine is by rhizoma zingiberis, Ligusticum wallichii, Radix Angelicae Sinensis, radix glycyrrhizae, radix scutellariae, osmanthus heart, almond, gypsum, Huang
Fiber crops composition.
2. a kind of medicine according to claim 1, it is characterised in that each component of described medicine example in mass ratio is matched
It is as follows：1 part of rhizoma zingiberis；Ligusticum wallichii, each 0.8 ~ 1.5 part of Radix Angelicae Sinensis, radix glycyrrhizae, radix scutellariae；Each 8 ~ 12 parts of osmanthus heart, almond；Gypsum, jute each 15 ~
25 parts.
3. a kind of medicine according to claim 2, it is characterised in that each component of described medicine example in mass ratio is matched
It is as follows：Rhizoma zingiberis, Ligusticum wallichii, each 1 part of Radix Angelicae Sinensis, radix glycyrrhizae, radix scutellariae；Each 10 parts of osmanthus heart, almond；Each 20 parts of gypsum, jute.
4. a kind of medicine according to claim 1, it is characterised in that the formulation of described medicine can be decoction, pill,
The medically acceptable formulation such as powder, tablet, capsule, granule.
5. a kind of medicine according to claim 1-4, it is characterised in that described medicinal application is in treatment apoplexy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710360148.XA CN106983849A (en) | 2017-05-20 | 2017-05-20 | A kind of Chinese medicine for treating apoplexy and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710360148.XA CN106983849A (en) | 2017-05-20 | 2017-05-20 | A kind of Chinese medicine for treating apoplexy and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106983849A true CN106983849A (en) | 2017-07-28 |
Family
ID=59420411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710360148.XA Withdrawn CN106983849A (en) | 2017-05-20 | 2017-05-20 | A kind of Chinese medicine for treating apoplexy and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106983849A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108187018A (en) * | 2018-03-15 | 2018-06-22 | 天津白大夫健康管理有限公司 | One kind prolongs raw granular recipe |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11349487A (en) * | 1998-06-03 | 1999-12-21 | Kwang Dong Pharmaceut Co Ltd | Woowhangchungshimwon composition of new recipe and its production |
| CN102895632A (en) * | 2011-07-29 | 2013-01-30 | 苏州知微堂生物科技有限公司 | Preparation technology and production method for integrated new formulation of life-prolonging decotion |
-
2017
- 2017-05-20 CN CN201710360148.XA patent/CN106983849A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11349487A (en) * | 1998-06-03 | 1999-12-21 | Kwang Dong Pharmaceut Co Ltd | Woowhangchungshimwon composition of new recipe and its production |
| CN102895632A (en) * | 2011-07-29 | 2013-01-30 | 苏州知微堂生物科技有限公司 | Preparation technology and production method for integrated new formulation of life-prolonging decotion |
Non-Patent Citations (3)
| Title |
|---|
| 吴积海: "脑中风从肺论治", 《河南中医学院学报》 * |
| 张永全: "《古今录验》续命汤新用", 《新中医》 * |
| 陈川等: "《中医名方临床集验》", 31 January 2017, 上海科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108187018A (en) * | 2018-03-15 | 2018-06-22 | 天津白大夫健康管理有限公司 | One kind prolongs raw granular recipe |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104689173B (en) | A kind of compound Chinese medicinal preparation for treating gout | |
| CN104173458B (en) | A kind of have Chinese medicine composition preventing and treating hyperuricemia effect and preparation method thereof | |
| CN101129485A (en) | Pyrrosia lingua farw Tonglin beverage | |
| CN102579610B (en) | Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN106983849A (en) | A kind of Chinese medicine for treating apoplexy and application | |
| CN100553673C (en) | The Chinese patent medicine of treatment chronic pharyngitis | |
| CN102335370B (en) | Flavored medicinal composition for removing stasis and dredging collaterals, and preparation method thereof | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN103920058A (en) | Traditional Chinese medicine preparation for treating headache and preparation method thereof | |
| CN103830482A (en) | Traditional Chinese medicine preparation for treating stroke and preparation method thereof | |
| CN102349979A (en) | Oral traditional Chinese medicine composition for treating bitter taste in mouth | |
| CN103340972B (en) | Traditional Chinese medicine composition for treating traumatic injuries | |
| CN103041362B (en) | Drug for treating rheumatism and rheumatoid and preparation method thereof | |
| CN102106999A (en) | Chinese medicinal compound preparation for treating dysphagia due to stroke and preparation method thereof | |
| CN102302655B (en) | Loquat acne removing capsules | |
| CN105456624A (en) | Traditional Chinese medicine caring composition for post-partum recovery and preparation method thereof | |
| CN105147994A (en) | Traditional Chinese medicine preparation for treating diabetes and preparation method thereof | |
| CN107137683A (en) | A kind of medicine for treating apoplexy and application | |
| CN107137682A (en) | A kind of Chinese medicine composition for treating apoplexy and application | |
| CN103751624B (en) | A kind of medicine and preparation method for the treatment of numb limbs and tense tendons after apoplexy | |
| CN107441330A (en) | A kind of Chinese medicine composition for treating coronary heart disease and the deficiency of vital energy | |
| CN105148212A (en) | Traditional Chinese medicine composition for treating diabetes and hypertension combined disease | |
| CN104096038A (en) | Traditional Chinese medicine wine for treating migraine | |
| CN104758503B (en) | It is a kind of promote union composition and its decocting liquid preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170728 |